Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Clinical trial NCT07379827 · RECRUITING
Trial details
- NCT number
- NCT07379827
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-26
- Primary completion
- 2028-06-20
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.